163 related articles for article (PubMed ID: 11347262)
1. Rare non-albicans Candida species detected in different clinical diagnoses.
Dorko E; Kmetová M; Pilipcinec E; Bracoková I; Dorko F; Danko J; Svický E; Tkáciková L
Folia Microbiol (Praha); 2000; 45(4):364-8. PubMed ID: 11347262
[TBL] [Abstract][Full Text] [Related]
2. Fungal diseases of the respiratory tract.
Dorko E; Pilipcinec E; Tkáciková L
Folia Microbiol (Praha); 2002; 47(3):302-4. PubMed ID: 12094743
[TBL] [Abstract][Full Text] [Related]
3. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
4. Candidal urinary tract infections caused by non-albicans Candida species.
Dorko E; Pilipcinec E; Tkáciková L
Folia Microbiol (Praha); 2002; 47(2):182-4. PubMed ID: 12058399
[TBL] [Abstract][Full Text] [Related]
5. Non-albicans Candida species isolated from plastic devices.
Dorko E; Kmet'ová M; Marossy A; Dorko F; Molokácová M
Mycopathologia; 1999 Dec; 148(3):117-22. PubMed ID: 11189762
[TBL] [Abstract][Full Text] [Related]
6. Candidaemia in cancer patients and in children in a neonatal intensive care unit.
Trubenová D; Virágová S; Pilipcinec E; Danko J; Svický E; Tkáciková L
Folia Microbiol (Praha); 2001; 46(2):161-4. PubMed ID: 11501406
[TBL] [Abstract][Full Text] [Related]
7. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains.
Kantarcioglu AS; Yücel A
Mycoses; 2002 Jun; 45(5-6):160-5. PubMed ID: 12100532
[TBL] [Abstract][Full Text] [Related]
9. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
10. Candida biotypes isolated from clinical specimens in Malaysia.
Ng KP; Madasamy M; Saw TL; Baki A; He J; Soo-Hoo TS
Mycopathologia; 1998-1999; 144(3):135-40. PubMed ID: 10531679
[TBL] [Abstract][Full Text] [Related]
11. Clinical microbiology of neonatal candidiasis in Hungary.
Kristóf K; Janik L; Komka K; Harmath A; Hajdú J; Nobilis A; Rozgonyi F; Nagy K; Rigó J; Szabó D
Acta Microbiol Immunol Hung; 2010 Dec; 57(4):407-17. PubMed ID: 21183426
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Candida species isolated from human skin and nails: a survey.
Jautová J; Virágová S; Ondrasovic M; Holoda E
Folia Microbiol (Praha); 2001; 46(4):333-7. PubMed ID: 11830946
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease.
el-Mohandes AE; Johnson-Robbins L; Keiser JF; Simmens SJ; Aure MV
Pediatr Infect Dis J; 1994 Jun; 13(6):520-4. PubMed ID: 8078741
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method in the identifi cation of Candida species isolated from blood cultures].
Aydemir G; Koç AN; Atalay MA
Mikrobiyol Bul; 2016 Apr; 50(2):293-9. PubMed ID: 27175502
[TBL] [Abstract][Full Text] [Related]
15. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
Aquino VR; Lunardi LW; Goldani LZ; Barth AL
Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples].
Gayibova Ü; Dalyan Cılo B; Ağca H; Ener B
Mikrobiyol Bul; 2014 Jul; 48(3):438-48. PubMed ID: 25052110
[TBL] [Abstract][Full Text] [Related]
18. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification and distribution profile of Candida species isolated from Iranian patients.
Mohammadi R; Mirhendi H; Rezaei-Matehkolaei A; Ghahri M; Shidfar MR; Jalalizand N; Makimura K
Med Mycol; 2013 Aug; 51(6):657-63. PubMed ID: 23470036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
